ACTRN12614000491662尚未招募1 期
For patients with advanced head and neck squamous cell carcinoma, does Cetuximab Radiolabelled with Gallium-68, Lutetium-177 or Rhenium-188 exhibit tumour uptake relative to background sufficiently to enable targeted radioimmunotherapy?
Dr Timothy Marr0 个研究点目标入组 30 人开始时间: 2014年5月12日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Histological evidence of head and neck squamous cell carcinoma.
- •Disease progression without option for further surgery or radiotherapy (palliation).
- •Able to provide informed consent.
排除标准
- •Option for further radiotherapy or salvage surgery
- •Non-squamous cell carcinoma head and neck cancer
研究者
相似试验
尚未招募
不适用
The Impact of Combined Modality Therapy on Sensorineural Hearing Loss in Patients with Head and Neck CancerSensorineural Hearing LossACTRN12615001300561Phoebe Shorter100
招募中
不适用
Importance of Nutritional Status in Prognosis of Head and Neck CancerCTRI/2020/12/030126Dr Shama Shetty
已完成
不适用
Detection of recurrent head and neck squamous cell carcinomas with DW-MRI after (chemo)radiatiohypopharyngeal and oropharyngeal carcinomalaryngealoral and throat cancer10027655NL-OMON35371niversitair Medisch Centrum Utrecht74
已完成
不适用
outcomes of Head and neck cancer in HIV and Hepatitis B & C patients.CTRI/2018/04/012911A156
招募中
不适用
ymphoscintigraphy in head and neck patients treated with primary radiotherapyhead and neck cancerhead and neck squamous cell carcinoma10038666NL-OMON31486Vrije Universiteit Medisch Centrum20